Symbol
| GOT1
| contributors: mct/npt - updated : 08-10-2019
|
HGNC name
| glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)
|
HGNC id
| 4432
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| fusion
|  
|  
|  
|
ETV6/GOT1 fusion in a case of t(10;12)(q24;p13)-positive myelodysplastic syndrome (Struski 2008) | |
Susceptibility
|
to Macro-aspartate aminotransferase (macro-AST) |
Variant & Polymorphism
| missense variant (p.Gln208Glu, rs374966349) in GOT1 was found, as a putative causal variant predisposing to familial macro-AST |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | pancreas | |
therapy target in pancreatic ductal adenocarcinoma (PDAC) | cancer | endocrine | pancreas | |
small molecule inhibitors that target GOT1 could serve as starting points for the development of new therapies for pancreatic cancer | cancer | | | |
is a possible target in cancer therapy |
| | | |